What Types of Cancer Could Benefit from Lipase Inhibition?
The potential of lipase inhibitors spans various types of cancers. For instance, breast cancer, prostate cancer, and pancreatic cancer are known to have altered lipid metabolism pathways. Research indicates that targeting lipid metabolism with lipase inhibitors could specifically affect cancer types that show a dependence on lipid metabolic pathways, thus offering a targeted therapeutic approach.
